TY - JOUR
AU - W. Rioux
AU - B. Enns
AU - J. Jackson
AU - H. Quereshi
AU - M. Irvine
AU - S. M. Ghosh
A1 - 
AD - Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada.; Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada.; Faculty of Nursing, University of Calgary, Calgary, AB, Canada.; British Columbia Centre for Disease Control (BCCDC), Vancouver, BC, Canada.; Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada. ghosh@ualberta.ca.; Department of Internal Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada. ghosh@ualberta.ca.
AN - 37794482
BT - Subst Abuse Treat Prev Policy
C5 - Opioids & Substance Use; Financing & Sustainability
CP - 1
DA - Oct 4
DO - 10.1186/s13011-023-00565-8
DP - NLM
ET - 20231004
IS - 1
JF - Subst Abuse Treat Prev Policy
LA - eng
PY - 2023
SN - 1747-597x
SP - 57
ST - A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service
T1 - A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service
T2 - Subst Abuse Treat Prev Policy
TI - A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service
U1 - Opioids & Substance Use; Financing & Sustainability
U3 - 10.1186/s13011-023-00565-8
VL - 18
VO - 1747-597x
Y1 - 2023
ER -